
CALCIPOTRIENE 0.005% / NIACINAMIDE 4%
Qd Sincerus Florida. LLC. Adverse reactions s Active, inactive sd NDC 72934- 2033-2 CALCIPOTRIENE 0.005% / NIACINAMIDE 4%. Cream 30gm c.
Qd Sincerus Florida. LLC. Adverse reactions s Active, inactive sd NDC 72934- 2033-2 CALCIPOTRIENE 0.005% / NIACINAMIDE 4%. Cream 30gm c.
A Sincerus Florida. LLC .Adverse reactions c Active, inactive e NDC 72934-5034-3 CALCIPOTRIENE USP 0.005% / TRIAMCINOLONE ACETONIDE USP 0.1%. Ointment 60gm c.
Calcipotriene foam is indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. Calcipotriene foam is a…
Calcipotriene and Betamethasone Dipropionate Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp in patients 12 years and older and plaque psoriasis…
Calcipotriene and betamethasone dipropionate ointment is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. Calcipotriene and betamethasone…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.